Anavex Life Sciences Corp (AVXL)

[blu_1]

I thought the composition of matter expires in 2030. So, 4 years to wrap up another Ph3 for Alzheimers and then 12-16 months after that for the FDA to render a decision. Additional time for manufacturing, distribution, and marketing. So that takes us to 2008-2009 before patients will actually be prescribed 2-73 for Alzheimers and can start taking it. Yet I see no urgency on Anavex's part. Judging by the market's reaction to Daybue's approval, I don't see that Rett approval is gonna do much for the share price, *maybe* a 30% jump? Could get AVXL to $13, but not $100+. Missling is talking like Anavex is on the verge of commercialization. Yah right. I'll believe that when I see it. The logo for the company should be a snail or tortoise. Why are you wasting your time on a company that is so far removed from *possible* Alzheimers commercialization, when you also don't trust the company's management nor the performance of its lead compound?